News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New cancer-preventing role found for DNA ‘cable tie’
A ring of proteins that holds our chromosomes together as they replicate also plays a vital role in stopping DNA damage from leading to cancer, according to new research.
.png?sfvrsn=e5be7df6_2 "Cell division (green 4.3)")
Cell death triggers keep cancer at bay in healthy cells
Two molecules with the power of life and death over cells also play a key role in protecting the genome and preventing cancer, a major new study reveals.
New organ sparing radiotherapy plan could reduce treatment side effects
A new way to plan radiotherapy could help shape treatment away from sensitive organs near tumours to reduce side-effects, a new study shows.
Capturing cancer on the move – ICR photography competition showcases stunning images of tumour cells in action
Every year our researchers submit outstanding pictures to our Science and Medical Imaging Competition – telling a story about our pioneering work and its benefits for patients. Check out the fantastic images selected by our judges, and this year voted for by the public.
ICR hails £350m tender as ‘major milestone’ for London Cancer Hub
The Institute of Cancer Research, London, has welcomed the launch of a £350 million tender to find a commercial development partner for The London Cancer Hub as a major milestone in turning the vision for the project into reality.
Tackling tumour scar tissue could be key to treating pancreatic cancer
The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.
New ‘Trojan horse’ cancer treatment shows early promise in multiple tumour types
A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types.
Key signalling protein linked to aggressive cancers
Scientists have identified a protein which is associated with more aggressive breast, colorectal and ovarian cancers, which could be used to assist the diagnosis and development treatments for these cancers.
Partnering to Defeat Cancer: Babraham Research Campus hosts ICR networking event for our scientists and potential new commercial partners
The Institute of Cancer Research, London’s Enterprise Unit played host to scientists and possible future partners from the commercial sector to discuss opportunities to work together to defeat cancer.
High-precision radiotherapy can safely treat prostate cancer spread
Men with ‘high risk’ prostate cancer can safely receive high-dose radiotherapy to kill cancer cells that have spread into neighbouring lymph nodes, a new study reports.
New AI ‘shapeshift’ test identifies women with ‘very high risk’ ovarian cancer
Scientists have developed a new test that scans the shapes of tumour cells to pick out women with especially aggressive ovarian cancer, so treatment can be tailored to their needs.
The Royal Marsden’s Martin Gore dies unexpectedly
The ICR is shocked to learn that Professor Martin Gore, former Medical Director at The Royal Marsden, has died suddenly.
